Screener
Beta Bionics BBNX EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Beta Bionics’s reported figures.
Based on trailing twelve months.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
FAQ
- What is Beta Bionics's EBITDA margin?
- Beta Bionics (BBNX) reported EBITDA margin of -67.9% in Q2 2026.
- How has Beta Bionics's EBITDA margin changed year-over-year?
- Beta Bionics's EBITDA margin increased by 13.6% year-over-year, from -78.6% to -67.9%.
- What is the long-term trend for Beta Bionics's EBITDA margin?
- Over 2 years (2023 to 2025), Beta Bionics's EBITDA margin has grown at a -50.8% compound annual growth rate (CAGR), from -288.7% to -69.9%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Beta Bionics's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude